Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Bone Tumor or Soft Tissue Tumor
and you are
over 18
years old
-
The phase for this study is not defined.
Show me locations

The purpose

The purpose is to compare and evaluate multiple functional imaging methods (perfusion, diffusion, spectroscopy) for initial benign/malignant characterization of osteoarticular tumors and to determine which method or which association of methods could improve non invasive tissue characterization. Secondary purposes are: - to determine a possible correlation between some parameters and the histological grade (FNCLCC) - to suggest a coherent diagnostic imaging approach for osteoarticular tumors. The ancillary study will enroll patients needing radiological tumor follow-up. The purpose is to identify tools for evaluation of tumor activity and therapeutic response before modification of morpho-volumetric data.

Provided treatments

  • Other: Ecography
  • Other: CT scan
  • Other: MRI
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02895633. The sponsor of the trial is Central Hospital, Nancy, France and it is looking for 1090 volunteers for the current phase.
Official trial title:
Osteoarticular Tumor Characterization by Advanced Imaging